Immunomodulation of bivalent Newcastle disease DNA vaccine induced immune response by co-delivery of chicken IFN-γ and IL-4 genes

Veterinary Immunology and Immunopathology

Volumn 144, Issue 1-2, 2011, Pages 36-44

  Sawant, P M ^a   Verma, P C ^a   Subudhi, P K ^a   Chaturvedi, U ^a   Singh, M ^a   Kumar, Rajeev ^a   Tiwari, A K ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Chicken; DNA vaccine; Genetic adjuvants; Immunomodulation; Interferon gamma; Interleukin 4; Newcastle disease

Indexed keywords

ADJUVANT; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN Y; INTERLEUKIN 4; TETRAZOLIUM;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; ASSAY; BACTERIAL GENE; BIRD DISEASE; CELL; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CHICKEN; CLONE; CLONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE CONSTRUCT; GENE EXPRESSION; GENETICS; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE; LYMPHOCYTE TRANSFORMATION TEST; NEWCASTLE DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION TESTS; IMMUNITY, ACTIVE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; VACCINES, DNA; VIRAL VACCINES;

GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 82555191082     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.07.006     Document Type: Article

References (45)

1. Arai K.I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 1990, 59:783-836.
2. Asif M., Jenkins K.A., Hilton L.S., Kimpton W.G., Lowenthal J.W. Cytokine as adjuvants for avian vaccines. Immunol. Cell Biol. 2004, 82:638-643.
3. Asplin F.D. Immunisation against Newcastle disease with virus of low virulence (strain F) and observations on sub-clinical infection in partially resistant fowls. Vet. Rec. 1952, 64:245-249.
4. Avery S., Rothwell L., Degen W.D., Schijns V.E., Young J., Kaufman J., Kaiser P. Characterization of the first nonmammalian T2 cytokine gene cluster: the cluster contains functional single-copy genes for IL-3, IL-4, IL-13 and GM-CSF, a gene for IL-5 that appears to be pseudogene, and a gene encoding another cytokine like transcript, KK34. J. Interferon Cytokine Res. 2004, 24(10):600-610.
5. Binjawadagi B., Hari Babu Y., Sreekumar E. Immunomodulatory effect of recombinant chicken interferon-gamma (rchIFN-γ) on specific and non-specific immune responses in chicken vaccinated against Newcastle Disease Virus (NDV). Int. J. Poult. Sci. 2009, 8(2):122-127.
6. Bochkov Y.A., Palmenberg A.C. Translational efficiency of EMCV IRES in bicistronic vectors is dependent upon IRES sequence and gene location. Biotechniques 2006, 41:283-292.
7. Briggs D.J., Skeeles J.K. An enzyme linked immunosorbent assay for detecting antibodies to Pasteurella multocida in chickens. Avian Dis. 1984, 28(1):208-215.
8. Chaturvedi U., Kalim S., Desai G., Ratta B., Kumar R., Ravindra P.V., Kumar S., Dash B.B., Tiwari S., Sahoo A.P., Tiwari A.K. Development and in vitro characterization of a bivalent DNA containing HN and F genes of velogenic Newcastle disease virus. Indian J. Exp. Biol. 2011, 49:140-145.
9. Digby M.R., Lowenthal J.W. Cloning and expression of the chicken interferon-gamma gene. J. Interferon Cytokine Res. 1995, 15:939-945.
10. Fallon P.G., Jolin H.E., Smith P., Emson C.L., Townsend M.J., Fallon R., Smith P., McKenzie A.N. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002, 17(1):7-17.
11. Gurunathan S., Klinman D.M., Seder R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 2000, 18:927-974.
12. Heckert R.A., Elankumaran S., Oshop G.L., Vakharia V.N. A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization. Vet. Immunol. Immunopathol. 2002, 89(1-2):67-81.
13. Heeg K., Zimmermann S. CpG DNA as a Th1 trigger. Int. Arch. Allergy Immunol. 2000, 121(2):87-97.
14. Keestra A.M., de Zoete M.R., Bouwman L.I., van Putten J.P. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J. Immunol. 2010, 185(1):460-467.
15. Kim J.J., Yang J., VanCott T.C., Lee D.J., Manson K.H., Wyand M.S., Boyer J.D., Ugen K.E., Weiner D.B. Modulation of antigen-specific humoral responses in Rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants. J. Virol. 2000, 74(7):3427-3429.
16. Liu L., Zhou X., Hua Liu., Xiang L., Yuan Z. CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination. Immunology 2005, 115:223-230.
17. Loke C.F., Omar A.R., Raha A.R., Yusoff K. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet. Immunol. Immunopathol. 2005, 106:259-267.
18. Long J.E., Huang L.N., Qin Z.Q., Wang W.Y., Qu D. IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection. World J. Gastroenterol. 2005, 11(32):4967-4973.
19. Lowenthal J.W., Digby M.R., York J.J. Production of interferon-γ by T chicken cells. J. Interferon Cytokine Res. 1995, 15:933-938.
20. Lowenthal J.W., York J.J., O'Neil J.J., Rhode S.S., Prowse S.J., Digby M., Strom D.G. In vivo effects of chicken IFN-γ during infection with Eimeria. J. Interferon Cytokine Res. 1997, 17(9):551-558.
21. Lowenthal J.W., O'Neil T.E., Broadway M., Strom D.G., Digby M.R., Andrew M., York J.J. Co-administration of IFN-γ enhances antibody responses in chickens. J. Interferon Cytokine Res. 1998, 18:617-622.
22. Manickan E., Yu Z., Rouse B.T. DNA immunization of neonates induces immunity despite the presence of maternal antibody. J. Clin. Investig. 1997, 100:2371-2375.
23. Min W., Lillehoj H.S., Burnside J., Weining K.C., Staeheli P., Zhu J.J. Adjuvant effects of IL-1 beta, IL-2, IL-8, IL- 15, IFN-alpha, IFN-gamma, TGF-beta4 and lymphotactin on DNA vaccination against Eimeria acervulina. Vaccine 2001, 20:267-274.
24. Nagai Y. Protease-dependent virus tropism and pathogenicity. Trends Microbiol. 1993, 1:81-87.
25. Ni J., Schirrmacher V., Fournier P. The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination. Vaccine 2010, 28(42):6891-6900.
26. OIE, 2009. Newcastle Disease, Manual for Diagnostic Tests and Vaccines for Terrestrial Animals. Paris, France, pp. 576-589 (Chapter 2.3.14).
27. Paul W.E. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991, 77:1859-1870.
28. Pertmer T.M., Oran A.E., Moser J.M., Madorin C.A., Robinson H.L. DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to Hemagglutinin and Nucleoprotein. J. Virol. 2000, 74(17):7787-7793.
29. Potier L., Monteil M., Houdayer C., Eloit M. Study of the delivery of the gD gene of pseudorabies virus to one-day-old piglets by adenovirus or plasmid DNA as ways to by-pass the inhibition of immune response by colostral antibodies. Vet. Microbiol. 1997, 55:75-80.
30. Rajawat Y.S., Sundaresan N.R., Ravindra P.V., Kantaraja C., Ratta B., Sudhagar M., Rai A., Saxsena V.K., Palia S.K., Tiwari A.K. Immune responses induced by DNA vaccines encoding Newcastle virus haemagglutinin and/or fusion proteins in maternal antibody-positive commercial broiler chicken. Br. Poult. Sci. 2008, 49(2):111-117.
31. Ravindra P.V., Tiwari A.K., Sharma B., Rajawat Y.S., Ratta B., Palia S., Sundaresan N.R., Chaturvedi U., Kumar G.B., Chindera K., Saxena M., Subudhi P.K., Rai A., Chauhan R.S. HN protein of Newcastle disease virus causes apoptosis in chicken embryo fibroblast cells. Arch. Virol. 2008, 153(4):749-754.
32. Ravindra P.V., Tiwari A.K., Ratta B., Chaturvedi U., Palia S.K., Subudhi P.K., Kumar R., Sharma B., Rai A., Chauhan R.S. Induction of apoptosis in Vero cells by Newcastle disease virus requires viral replication, de-novo protein synthesis and caspase activation. Virus Res. 2008, 133(2):285-290.
33. Rees S., Coote J., Stables J., Goodson S., Harris S., Lee M.G. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques 1996, 20:102-110.
34. Reynolds D.L., Maraqa A.D. Protective immunity against Newcastle disease virus: the role of cell-mediated immunity. Avian Dis. 2000, 44:145-154.
35. Reynolds D.L., Maraqa A.D. Protective immunity against Newcastle disease virus: the role of antibodies specific to Newcastle disease virus polypeptides. Avian Dis. 2000, 44:138-144.
36. Sakaguchi M., Nakamura H., Sonoda K., Hamada F., Hirai K. Protection of chickens from Newcastle disease by vaccination with a linear DNA expressing the F protein of Newcastle disease virus. Vaccine 1996, 14:747-752.
37. Schijns V.E., Weining K.C., Nuijten P., Rijke E.O., Staeheli P. Immunoadjuvant activities of E. coli- and plasmid expressed recombinant chicken IFN-alpha/beta, IFN-gamma and IL-1β in 1-day- and 3-week-old chickens. Vaccine 2000, 18:2147-2154.
38. Siddiqui A.A., Phillips T., Charest H., Podesta R.B., Quinlin M.L., Pinkston J.R., Lloyd J.D., Paz M., Villalovos R.M., Pompa J. Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of GMCSF and interleukin 4. Infect. Immun. 2003, 71(1):3844-3851.
39. Siegrist C.A., Barrios C., Martinez X., Brandt C., Berney M., Cordova M., Kovarik J., Lambert P.H. Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice. Eur. J. Immunol. 1998, 28:4138-4148.
40. Snapper C.M., Peschel C., Paul W.E. IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 1988, 140:2121-2127.
41. Song K.D., Lillehoj H.S., Choi K.D., Zarlenga D., Han J.Y. Expression and functional characterization of recombinant chicken interferon-gamma. Vet. Immunol. Immunopathol. 1997, 58:321-333.
42. Tayade C., Jaiswal T.N., Mishra S.C., Koti M. L-Arginine stimulates immune response in chickens immunized with intermediate plus strain of infectious bursal disease vaccine. Vaccine 2006, 24:552-560.
43. Wang Y., Xiang Z., Pasquini S., Ertl H.C. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus. J. Virol. 1998, 72:1790-1796.
44. Weining K.C., Schultz U., Munster U., Kaspers B., Staeheli P. Biological properties of recombinant chicken interferon gamma. Eur. J. Immunol. 1996, 26:2440-2447.
45. Yuan H., Youn-en S., Long-jiang Y., Xiao-hua Z., Liu-zhe L., Cash M., Lu Z., Zhi L., Deng-xin S. Studies on the protective immunity of Schistosoma japonicum bivalent DNA vaccine encoding Sj23 and Sj14. Exp. Parasitol. 2007, 115:379-386.